https://www.novartis.com/jp-ja/
2024-03-19T10:55:13+09:00
daily
1.0
https://www.novartis.com/jp-ja/media-library/meteiaraifurari
2022-11-15T16:46:10+09:00
daily
1.0
https://www.novartis.com/jp-ja/node/286
2022-12-02T00:25:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers
2022-11-18T10:52:14+09:00
daily
1.0
https://www.novartis.com/jp-ja/access
2021-11-10T20:09:38+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance
2022-11-18T00:39:58+09:00
daily
1.0
https://www.novartis.com/jp-ja/environmental-sustainability
2021-11-10T20:12:11+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/diversity-and-inclusion
2022-07-29T14:58:53+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture
2023-07-28T18:18:54+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/strategy
2022-11-18T02:38:20+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethical-behavior
2022-11-08T13:40:56+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethical-behavior/code-ethics
2023-01-31T16:48:58+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethical-behavior/speakup
2024-02-13T13:57:06+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-japan/credibility
2022-11-18T00:59:39+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-japan/our-purpose-and-vision
2022-06-10T20:51:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/our-values
2022-09-09T13:18:39+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-japan/our-leadership
2022-08-31T13:55:27+09:00
daily
1.0
https://www.novartis.com/jp-ja/careers/newgrads
2023-11-15T11:56:20+09:00
daily
1.0
https://www.novartis.com/jp-ja/privacy-policy
2022-06-09T17:00:28+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/corporate-responsibility/access-to-medicine
2022-05-05T16:05:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/transparency
2022-06-09T21:50:33+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/culture
2022-06-08T21:17:07+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-japan/company-history
2023-10-04T09:11:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/guideline
2022-06-08T20:57:43+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/support-activity/grant
2022-06-08T20:40:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/adverse-event-report
2022-06-08T20:57:25+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board
2022-06-14T17:57:08+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20131118
2022-06-14T17:51:37+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20140128
2022-06-14T17:53:48+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20140227
2022-06-14T17:55:36+09:00
daily
1.0
https://www.novartis.com/jp-ja/careers/disabled
2022-06-14T19:33:09+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20140325
2022-06-14T17:56:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20140414
2022-06-09T13:55:35+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20140421
2022-06-09T13:59:12+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20140530
2022-06-09T14:00:31+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20140620
2022-06-09T14:02:07+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20140731
2022-06-09T14:04:39+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20140904
2022-06-09T14:06:32+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people
2023-10-31T10:54:53+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-japan/novartis-pharma/office-locations
2024-01-15T16:57:18+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20141028
2022-06-09T14:07:46+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit
2022-11-18T03:19:52+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20150116
2022-06-14T18:15:09+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20150409
2022-06-09T14:10:32+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20150703
2022-06-09T14:13:37+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance-advisory-board/compliance-adb-20151028
2022-06-09T14:14:39+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report
2022-06-14T14:19:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/corporate-responsibility
2022-06-14T21:11:43+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-japan/novartis-pharma
2024-02-20T10:37:34+09:00
daily
1.0
https://www.novartis.com/jp-ja/terms-use
2022-06-09T14:42:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-cookies
2022-06-09T17:14:23+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/disease-information
2022-12-09T13:48:01+09:00
daily
1.0
https://www.novartis.com/jp-ja/innovation/research-development/our-approach-to-drug-discovery/oncology
2022-06-13T15:08:38+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/clinical-trial
2022-06-08T15:14:03+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/clinical-trial/what-is-a-clinical-trial
2022-06-08T16:09:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/clinical-trial/ongoing-clinical-trial
2023-03-13T13:33:11+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-japan/license
2022-06-07T14:39:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-japan/license/benefit
2022-06-07T14:42:12+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/institute
2022-11-15T09:10:35+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support
2022-06-10T19:39:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/care
2022-07-21T17:51:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/care/care1
2022-06-10T14:38:49+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/care/care2
2022-06-10T16:10:11+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/care/care3
2022-06-10T16:57:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/care/care4
2022-06-10T17:54:31+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/daily-life
2022-06-10T15:55:37+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/daily-life/daily-life1
2022-06-13T19:41:14+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/daily-life/daily-life2
2022-06-13T19:44:06+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/touch-the-heart
2022-06-10T21:35:48+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/touch-the-heart/family
2022-06-10T16:09:11+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/daily-life/daily-life3
2022-06-13T19:45:52+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/daily-life/daily-life4
2022-06-13T19:47:05+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/touch-the-heart/friend
2022-06-10T16:17:52+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/child
2022-06-10T15:11:12+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/child/child1
2022-06-13T19:49:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/touch-the-heart/hcp
2022-06-10T16:19:02+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/child/child2
2022-06-13T19:50:54+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/child/child3
2022-06-13T19:59:52+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/touch-the-heart/patient
2022-06-10T16:20:41+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/child/child4
2022-06-13T20:01:21+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/touch-the-heart/others
2022-06-10T16:21:46+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/disaster
2022-06-10T15:19:07+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/disaster/disaster1
2022-06-13T20:16:20+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/disaster/disaster2
2022-06-13T20:17:25+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/disaster/disaster3
2022-06-13T20:19:17+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/support/disaster/disaster4
2022-06-13T20:20:33+09:00
daily
1.0
https://www.novartis.com/jp-ja/contact/novartis-direct
2024-01-05T14:57:53+09:00
daily
1.0
https://www.novartis.com/jp-ja/our-work/products-for-patients
2022-05-05T16:05:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/research-development/clinical-pipeline
2022-06-13T21:20:28+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/news-archive
2022-06-10T15:13:57+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/press-room/npkk-annual-results
2024-02-05T10:20:27+09:00
daily
1.0
https://www.novartis.com/jp-ja/research-development/japan-s-development-pipeline-press-room
2024-03-21T09:57:33+09:00
daily
1.0
https://www.novartis.com/jp-ja/maintenance/info1.html
2022-06-14T21:35:44+09:00
daily
1.0
https://www.novartis.com/jp-ja/maintenance/info2.html
2022-06-14T21:58:57+09:00
daily
1.0
https://www.novartis.com/jp-ja/maintenance/info3.html
2022-06-14T20:34:48+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/mr2
2022-06-08T16:26:16+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/medical2
2022-06-08T16:49:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/msl1
2022-06-08T16:34:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/msl2
2022-06-08T16:47:09+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/msl3
2022-06-08T16:52:12+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/ciba1
2022-06-08T17:43:49+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/ciba2
2022-06-08T16:55:57+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/clinical-trial/ongoing-clinical-trial/aih
2022-12-23T09:12:44+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/patients-caregivers
2023-10-04T09:16:42+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/mr3
2022-06-08T16:15:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/mr4
2022-06-08T16:23:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people/medical3
2022-06-08T16:42:22+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/disease-information/jia
2022-07-21T17:58:09+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/transparency/p2017
2022-12-05T16:43:59+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients
2022-11-21T19:02:01+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/disease-onc-hold-hands
2022-06-13T16:21:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/disease-onc-noone
2022-06-13T16:21:34+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/disease-onc-whats-cancer
2022-06-13T16:22:09+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/disease-onc-want-know
2022-07-21T15:52:45+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/disease-onc-inform
2022-06-13T16:23:31+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/disease-onc-how-to-do
2022-06-13T16:23:58+09:00
daily
1.0
https://www.novartis.com/jp-ja/our-work/support-for-patients/disease-onc-words
2022-05-05T16:05:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/our-work/support-for-patients/related-information
2022-05-05T16:05:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/press-room/kymriah-download
2022-11-25T16:36:27+09:00
daily
1.0
https://www.novartis.com/jp-ja/research-development/car-t
2022-07-26T09:22:13+09:00
daily
1.0
https://www.novartis.com/jp-ja/innovation/data-digital
2022-05-05T16:05:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-pharma/diversity-and-inclusion/inclusive
2022-06-14T21:53:45+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-pharma/diversity-and-inclusion/life-work
2022-05-05T16:05:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-pharma/diversity-and-inclusion/lgbt
2022-05-05T16:05:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-pharma/diversity-and-inclusion/child-care
2022-06-13T16:20:19+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-pharma/diversity-and-inclusion/women
2022-06-09T20:05:23+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/corporate-responsibility/pharmaceutical
2022-06-14T21:48:34+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/corporate-responsibility/japan
2022-07-29T15:16:52+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/corporate-responsibility/m-cr
2022-07-29T15:12:45+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/corporate-responsibility/m-access
2022-06-14T20:41:12+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/corporate-responsibility/m-malaria
2022-06-14T20:48:49+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/corporate-responsibility/m-ict
2022-06-14T20:45:26+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/corporate-responsibility/m-biocamp
2022-06-14T20:51:45+09:00
daily
1.0
https://www.novartis.com/jp-ja/contact/product-information-offering
2024-01-05T15:01:49+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/transparency/p2018
2022-12-05T16:47:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/AYA-movie
2022-06-13T18:17:07+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-pharma/diversity-and-inclusion/parental-leave
2022-06-14T16:45:56+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/support-activity/basic-research
2024-01-05T14:48:33+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/support-activity/education
2024-01-05T13:39:33+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/support-activity
2023-06-16T09:13:07+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/around20
2022-06-13T18:25:44+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/ht
2022-10-20T17:52:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/diversity-and-inclusion/kenkoukeiei
2022-06-10T17:23:34+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/transparency/p2019
2022-12-05T16:53:47+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/support-for-patients/melanoma
2022-07-21T17:48:41+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/support-activity/grants
2024-01-05T15:02:48+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/support-activity/basic-research2021
2024-01-05T14:35:03+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/inspired
2022-07-21T13:29:09+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/curious
2022-07-21T13:31:19+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/unbossed
2022-07-21T13:33:25+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/transparency/p2020
2022-12-05T16:55:04+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/infographic
2024-02-26T17:53:41+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/support-activity/basic-research2022
2024-01-05T14:25:21+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/novartis-commitment-patients-and-caregivers/patient-engagement
2022-07-21T15:49:23+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/interview
2022-07-21T13:50:55+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/people-and-culture/our-people/people
2022-12-02T17:31:43+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us/novartis-japan/25th-anniversary
2023-10-04T09:14:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/clinical-trial/ongoing-clinical-trial/ahus
2023-02-14T16:02:04+09:00
daily
1.0
https://www.novartis.com/jp-ja/careers
2022-08-26T18:58:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/risk-management
2022-06-14T17:39:40+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/compliance
2022-06-14T17:42:14+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/press-conference-20150609
2022-07-21T14:09:26+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20130603
2022-06-09T15:18:01+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20130702
2022-06-09T15:18:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20130926
2022-06-09T15:15:20+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20140509
2022-06-14T14:25:47+09:00
daily
1.0
https://www.novartis.com/jp-ja/careers/meet-the-teams/development
2022-11-18T02:26:20+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20130930
2022-06-09T17:00:14+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20131002
2022-06-09T17:04:01+09:00
daily
1.0
https://www.novartis.com/jp-ja/careers/meet-the-teams/msl-position
2022-06-14T21:13:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140109
2022-06-09T17:46:48+09:00
daily
1.0
https://www.novartis.com/jp-ja/careers/meet-the-teams/production-engineering-job
2022-06-14T21:22:14+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20131003
2022-06-09T18:27:55+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20131109
2022-06-09T18:32:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/careers/meet-the-teams/mr-job
2022-06-14T21:27:03+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140123
2022-07-27T17:17:12+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20140609
2022-06-09T19:16:18+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20140731
2022-06-09T19:28:11+09:00
daily
1.0
https://www.novartis.com/jp-ja/koubai
2023-01-11T17:09:55+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20140829-1
2022-06-14T14:48:52+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20141001
2022-06-14T14:53:23+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20141216
2022-06-14T15:09:15+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140120
2022-06-09T20:32:07+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140206-1
2022-06-09T20:36:59+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20150227
2022-06-09T20:40:57+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140206
2022-07-26T10:11:47+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20151113-1
2022-06-14T16:02:09+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20151113-2
2022-06-09T20:52:34+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-adverse-event-report/bg-aer-20151211
2022-06-14T16:14:48+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140314
2022-07-26T10:16:38+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140402
2022-06-10T13:43:29+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140403
2022-06-10T13:48:11+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140407
2022-06-14T19:45:49+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140519
2022-07-26T10:29:46+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140611
2022-06-14T19:50:34+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/transparency/agreement-transparency
2023-11-02T09:41:46+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140701
2022-06-14T18:58:29+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20140722
2022-06-14T18:51:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20151216
2022-06-14T18:45:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20170316
2022-06-14T18:37:17+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20170329
2022-06-14T18:34:39+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20181130
2022-06-14T18:31:13+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20130729
2022-06-14T20:36:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/ethics-risk-and-compliance/background-iit/bg-iit-20130906
2022-06-14T20:46:16+09:00
daily
1.0
https://www.novartis.com/jp-ja/healthcare-professionals/support-activity/ascvd-program2022
2024-01-05T14:56:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/press-room/novartis-financial-results
2023-03-09T09:17:58+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/transparency/p2021
2023-10-05T09:36:32+09:00
daily
1.0
https://www.novartis.com/jp-ja/test-honor-protection-onetrust-cookie
2022-10-14T20:26:56+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/media-releases-archive
2022-11-02T22:23:10+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/media-hub
2023-02-27T16:14:04+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/test_20221122
2023-10-13T16:57:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/test_20221124
2023-03-06T10:30:13+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/test_20221124_02
2022-11-24T17:40:23+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/test_20221124_03
2022-11-24T17:39:27+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/test_20221124_04
2022-12-15T16:31:22+09:00
daily
1.0
https://www.novartis.com/jp-ja/linkedin-community-guideline
2022-12-06T11:38:59+09:00
daily
1.0
https://www.novartis.com/jp-ja/research-development/technology-platforms/cell-therapy/charging-towards-next-generation-car-t
2023-07-28T13:34:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-cell-therapy-pioneering-cancer-therapy
2023-06-23T11:05:37+09:00
daily
1.0
https://www.novartis.com/jp-ja/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/a-revolutionary-cancer-therapy-made-from-patients-cells
2023-06-23T11:11:35+09:00
daily
1.0
https://www.novartis.com/jp-ja/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/about-novartis-gene-therapies
2023-06-23T11:20:18+09:00
daily
1.0
https://www.novartis.com/jp-ja/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/gene-therapy-manufacturing
2023-06-23T11:21:25+09:00
daily
1.0
https://www.novartis.com/jp-ja/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/resources-rare-disorders-patient-community
2023-06-23T11:22:28+09:00
daily
1.0
https://www.novartis.com/jp-ja/diseases/spinal-muscular-atrophy-sma
2023-06-23T11:23:10+09:00
daily
1.0
https://www.novartis.com/jp-ja/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/newborn-screening-spinal-muscular-atrophy-sma
2023-06-23T11:24:27+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/research-information
2024-02-19T09:13:04+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/research-information/nsclc
2023-07-31T17:16:34+09:00
daily
1.0
https://www.novartis.com/jp-ja/testyk
2023-08-08T09:08:48+09:00
daily
1.0
https://www.novartis.com/jp-ja/esg/transparency/p2022
2023-11-02T09:40:46+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/ongoing-development-of-new-medicine
2023-11-15T14:39:33+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/overview-of-clinical-trial-result
2023-10-23T09:32:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/nenkin
2023-11-27T15:28:51+09:00
daily
1.0
https://www.novartis.com/jp-ja/patients-and-caregivers/research-information/cact
2024-02-19T09:39:43+09:00
daily
1.0
https://www.novartis.com/jp-ja/about-us
2022-09-14T17:38:56+09:00
daily
0.5
https://www.novartis.com/jp-ja/home
2024-03-19T10:55:13+09:00
daily
0.5
https://www.novartis.com/jp-ja/esg
2022-08-09T23:14:43+09:00
daily
0.5
https://www.novartis.com/jp-ja/patients-and-caregivers
2023-10-23T09:37:46+09:00
daily
0.5
https://www.novartis.com/jp-ja/healthcare-professionals
2022-11-17T19:22:42+09:00
daily
0.5
https://www.novartis.com/jp-ja/news
2023-11-27T15:31:12+09:00
daily
0.5
https://www.novartis.com/jp-ja/about-us/novartis-japan
2024-03-22T17:45:54+09:00
daily
0.5
https://www.novartis.com/jp-ja/research-development
2023-11-06T14:38:21+09:00
daily
0.5
https://www.novartis.com/jp-ja/contact
2024-01-11T10:05:58+09:00
daily
0.5
https://www.novartis.com/jp-ja/careers/meet-the-teams
2022-07-29T14:25:01+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/press-room
2023-11-06T14:41:07+09:00
daily
0.5
https://www.novartis.com/jp-ja/healthcare-professionals/products
2022-07-19T17:31:28+09:00
daily
0.5
https://www.novartis.com/jp-ja/research-development/technology-platforms
2023-06-23T18:00:45+09:00
daily
0.5
https://www.novartis.com/jp-ja/research-development/technology-platforms/cell-therapy
2023-06-23T11:04:10+09:00
daily
0.5
https://www.novartis.com/jp-ja/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond
2023-07-28T13:38:45+09:00
daily
0.5
https://www.novartis.com/jp-ja/research-development/technology-platforms/gene-therapy
2023-07-28T13:39:33+09:00
daily
0.5
https://www.novartis.com/jp-ja/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies
2023-06-23T11:19:21+09:00
daily
0.5
https://www.novartis.com/jp-ja/research-development/technology-platforms/radioligand-therapy
2023-06-23T11:25:56+09:00
daily
0.5
https://www.novartis.com/jp-ja/patients-and-caregivers/clinical-trial
2024-03-21T09:56:11+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220111-2
2022-06-15T18:27:19+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220111-1
2022-06-15T18:23:26+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220114
2022-06-15T16:51:51+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220121
2022-06-13T15:27:26+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220126-1
2022-06-15T17:02:19+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220126-2
2022-06-15T17:05:40+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220131
2022-05-05T16:05:28+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220131-1
2022-06-13T16:35:50+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220207
2022-06-13T16:41:42+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220209-1
2022-06-15T17:25:14+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220209-2
2022-06-15T17:07:33+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220209-3
2022-06-15T16:51:09+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220210
2022-06-15T16:18:54+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220225
2022-06-15T16:10:53+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220301
2022-06-15T14:40:38+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220303
2022-06-15T15:41:43+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220328
2022-06-15T15:35:37+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220315
2022-06-15T15:40:02+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220404
2022-06-14T21:59:56+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220407
2022-06-15T15:31:30+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220413
2022-06-14T17:25:14+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220418
2022-06-14T17:40:06+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220422
2022-06-14T17:45:45+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220602
2022-06-14T16:37:21+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220513
2022-06-14T16:49:55+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220525-1
2022-11-18T03:39:23+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220525-2
2022-12-09T14:09:18+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220526
2022-07-08T15:37:06+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220531
2022-07-08T15:49:30+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220609
2022-07-08T16:07:02+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220616-1
2022-11-22T15:26:16+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220616-2
2022-07-08T16:49:07+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220617
2022-07-08T17:00:56+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220620
2022-07-08T17:22:15+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220621
2022-07-08T17:33:04+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220707
2022-07-08T17:41:32+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220711
2022-07-13T10:14:29+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220722
2022-08-24T17:24:05+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220728
2022-08-24T17:24:50+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220729
2022-12-06T11:53:06+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220822
2022-08-24T17:47:27+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220824
2022-08-24T17:53:43+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220826
2022-09-05T15:05:32+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220905
2022-09-05T14:27:57+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220912
2022-09-13T09:45:29+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220914
2022-09-15T14:13:51+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20221007
2022-10-13T10:07:38+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20220916
2022-10-18T10:47:15+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20221020
2022-10-20T13:31:56+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20221107
2022-12-06T11:50:20+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20221101
2022-11-09T15:20:35+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20221122
2022-11-25T09:27:19+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20221111
2022-11-25T14:51:47+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20221130
2022-12-01T10:37:35+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20221219
2022-12-19T13:08:55+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20221226
2022-12-26T09:51:48+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230110-2
2023-01-10T10:52:19+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230110-1
2023-01-10T10:51:37+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230220
2023-02-20T10:59:10+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230214
2023-02-14T13:51:18+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230324
2023-03-24T15:20:57+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230331
2023-03-31T10:50:55+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230512
2023-05-12T13:56:52+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230517
2023-05-17T10:55:26+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230531
2023-05-31T16:55:26+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230612
2023-06-12T15:51:46+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230627
2023-06-27T13:51:40+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230626
2023-06-26T14:23:09+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230712
2023-07-12T13:50:58+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230728
2023-07-28T09:52:06+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230823
2023-08-23T14:52:20+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230828
2023-08-28T13:52:10+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230830
2023-08-30T10:51:24+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230912
2023-09-12T10:52:13+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230921
2023-09-21T13:52:40+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230925
2023-09-25T17:32:14+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20230928
2023-09-28T13:51:08+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231011
2023-10-11T13:51:21+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231016
2023-10-16T11:50:52+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231013
2023-10-13T14:17:32+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231106
2023-11-06T13:52:36+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231107
2023-11-07T15:51:08+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231113
2023-11-13T13:52:15+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231114
2023-11-14T10:51:23+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231122
2023-11-22T09:01:37+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231124
2023-11-24T15:26:31+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231129
2024-03-14T11:08:19+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231208
2023-12-08T15:24:18+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231222
2023-12-22T15:22:05+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20231225
2023-12-25T15:31:19+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20240126-1
2024-01-26T10:10:59+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20240126-2
2024-01-26T12:54:52+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20240202
2024-02-02T10:51:56+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20240207
2024-02-07T14:11:40+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20240209-1
2024-02-09T11:00:42+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20240209-2
2024-02-09T15:22:04+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20240308
2024-03-08T09:51:57+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20240216
2024-02-16T13:52:58+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/media-releases/prkk20240326
2024-03-26T15:22:54+09:00
daily
0.5
https://www.novartis.com/jp-ja/news/pb20170403
2022-11-18T21:15:06+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20180629
2022-06-14T18:04:34+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20180706
2022-06-13T20:59:12+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20180904
2022-06-13T21:05:47+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20180828
2022-06-14T20:02:13+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20181011
2022-06-14T19:19:46+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20181108
2022-06-14T19:22:44+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20181119
2022-06-13T21:04:02+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20181130
2022-06-14T19:29:32+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20181226
2022-06-14T19:31:38+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20190305
2022-06-13T21:53:40+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20190308
2022-06-14T19:34:52+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20190301-wgw-apkk
2022-06-24T17:03:22+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20180227-wgw-apkk
2022-06-24T16:50:10+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20171010-apkk
2022-06-14T19:59:29+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20190927
2022-06-14T19:37:58+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20200306
2022-06-24T16:57:05+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/coronavirus-pb20200414
2022-06-10T13:44:41+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20201026
2022-06-14T17:56:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20210721
2022-06-13T20:18:15+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20210910
2022-06-14T17:51:54+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20220810
2022-08-26T17:52:49+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20220909
2022-11-18T02:54:34+09:00
daily
1.0
https://www.novartis.com/jp-ja/news/pb20231102
2023-11-02T16:32:46+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/life-dedicated-fighting-malaria
2023-07-10T10:03:07+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/shedding-skin-and-treating-psoriasis-uncovered-story-hidden-condition
2022-12-12T16:39:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/the-life-of-a-cancer-drug-at-novartis-oncology
2022-12-12T17:17:19+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/tailoring-tactics-tackle-chronic-disease-low-income-countries
2023-07-10T10:14:36+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/lung-cancer-test-or-not-test
2022-12-12T16:38:26+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/neuroscience
2022-12-12T17:16:27+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/fmf-patient
2023-02-20T16:45:36+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/malaria-bicycle
2023-07-10T10:17:06+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/mpn-patient
2022-06-15T18:10:20+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/cml-patient
2022-12-12T16:26:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/psoriasis-body-paint
2022-12-12T16:18:32+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/breast-cancer-patient
2022-12-12T16:17:44+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/acromegaly-patient
2022-12-12T16:15:54+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/diabetes-regenerative-medicine
2022-12-12T17:15:53+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/alk-nsclc
2022-12-12T17:14:13+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/pv-patient-runner
2022-12-12T16:11:02+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/kenya-chronic-diseases
2023-07-10T10:17:49+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/access-to-medicine
2023-07-10T10:20:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/tsc-patient
2022-12-12T16:06:58+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-all
2022-12-12T16:06:08+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-liver-trans
2022-12-12T16:05:20+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patiet-glaucoma
2022-12-12T16:02:33+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/nibr
2022-12-12T17:11:44+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-aml
2022-12-12T16:01:17+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/malaria-africa
2023-07-10T10:23:32+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/access-to-medicine-improve
2023-07-10T10:25:13+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/plants-research
2023-07-10T10:26:22+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-lung-cancer-stage4
2023-10-12T14:37:21+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-amd
2022-12-12T15:55:57+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/zika
2022-12-12T17:07:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-cf
2022-12-12T15:46:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-all-basketball
2022-12-12T15:45:14+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-sjia
2022-12-12T16:03:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/genome-aav
2022-12-12T17:06:19+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/wireless-monitoring
2022-12-12T17:05:25+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-alzheimer
2022-12-12T15:35:38+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/eye
2022-12-12T15:34:44+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-cml-aya
2022-12-12T15:33:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-psoriasis-comedian
2022-12-12T15:32:29+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-copd
2022-12-12T15:30:44+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/open-science
2022-12-12T17:04:15+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/vr-drug-design
2022-12-12T17:03:19+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/hypertension-cameroon
2023-07-10T10:27:32+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/biomarker-testing
2022-12-12T15:28:10+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-as
2022-06-15T18:45:24+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/machine-learning
2022-12-12T16:59:56+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/malaria-still
2023-07-10T10:29:21+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/indian-village
2023-07-10T10:30:50+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/novartis-biome
2022-12-12T16:58:46+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/marjorie-eiref
2023-07-10T10:07:13+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/cyndy-grosskreutz
2023-07-10T10:06:22+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/jennifer-allport-anderson
2023-07-10T10:05:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/tsc-patient2
2022-12-12T15:25:36+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-amd2
2022-12-12T15:19:30+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-melanoma
2022-12-12T15:17:15+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/breast-cancer-patient2
2022-12-12T15:14:35+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/asian-health-experts-call-final-push-wipe-out-deadliest-form-malaria
2023-07-10T10:31:33+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/improving-lives-through-community-based-care
2023-07-10T10:32:11+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/using-super-resolution-microscopy-see-neurodegeneration
2022-12-12T16:58:07+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/collaboration-strengthening-care-chronic-illness-ethiopia
2023-07-10T10:33:56+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/data42-program-shows-novartis-intent-go-big-data-and-digital
2022-12-12T16:56:54+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/investigating-myopia-mystery
2022-12-12T16:54:22+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/visualizing-molecular-glues
2022-12-12T16:52:13+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/guidance-system-lights-path-drug-discovery
2022-12-12T16:47:40+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-psoriasis
2022-12-12T15:12:49+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/interview-01
2022-12-12T15:08:36+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/interview-02
2022-12-12T15:07:28+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/interview-03
2022-12-12T15:06:45+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/interview-04
2022-12-12T15:06:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/interview-05
2022-12-12T15:02:17+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/interview-06
2022-12-12T15:01:01+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/interview-07
2022-12-09T14:15:39+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/people-and-culture/interview-08
2022-10-13T10:53:23+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/researchers-boost-understanding-t-cell-therapy-blood-cancer
2023-06-23T11:10:25+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/hardwiring-future
2023-06-23T18:01:23+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/collaborating-explore-new-gene-regulation-therapies
2023-06-23T11:13:57+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/bringing-gene-therapy-focus
2023-06-23T11:18:00+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/turning-power-nuclear-technology-medical-force
2023-06-23T11:28:36+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/discovery/not-your-grandparents-nuclear-medicine
2023-06-23T11:27:03+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/education-awareness/patient-ms
2023-02-22T10:37:54+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/career-challenge-day1
2023-07-10T13:12:49+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/social-responsibility/career-challenge-day2
2023-07-18T11:26:23+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/digital/dc1
2023-11-13T12:00:07+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/digital/dc2
2023-11-13T12:01:02+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/digital/dc3
2023-11-13T11:55:16+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/digital/cd-a1
2024-03-01T09:40:10+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/digital/cd-a4
2024-03-21T10:57:42+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/digital/cd-a3
2024-03-19T12:04:01+09:00
daily
1.0
https://www.novartis.com/jp-ja/stories/digital/cd-a2
2024-03-19T12:04:53+09:00
daily
1.0